Live
- Hailstorm-hit Vistara flight returns to Bhubaneswar airport
- PM Modi-led govt saved people during pandemic: Union Minister Anurag Thakur
- Heat wave grips Telangana, mercury crosses 46 degrees Celsius in few places
- New India believes in giving a dose, not dossiers, to terror masterminds: PM Modi
- Nagarkurnool MLA Kuchukulla Rajesh Reddy should send Malluravi to Parliament for the third time
- Awareness conference on Mayday under the auspices of Legal Service Authority
- Adani Power logs 37 per cent revenue growth in FY24, consolidated PBT more than doubled
- Rohit said 'just show us what you can do', recalls Shivam Dube post T20 WC selection
- Resignations of Lovely, Naseeb and Basoya indicate Congress high command's disconnect with ground reality
- Hamas standing in way of ceasefire, Blinken says during meeting with Israeli PM Netanyahu
Sandoz to set up its global centre in Hyderabad
Sandoz to set up its global centre in Hyderabad
The GCC will initially have 800 employees, and plans to increase to 1,800 people in future
Hyderabad: Sandoz, a global leader in generic pharmaceuticals and biosimilars, has announced setting up of their Global Capability Centre (GCC) in Hyderabad to provide support for their worldwide knowledge services. The center will initially have a workforce of 800 employees, with plans to increase to approximately 1,800 people in the near future.
Sandoz is a subsidiary of Swiss multinational pharmaceutical corporation Novartis. Cementing Hyderabad's leadership position in the pPharma and GCC space, the company made the announcement after its leadership - CEO (designate) Richard Saynor, Chief Scientific Officer Claire D'Abreau-Hayling, and Development Centre India Head Dr Vanadana Singh met with IT & Industries Minister KT Rama Rao here. Sandoz has a development center in Genome Valley (GV) engaged in cutting edge R&D facilities. The team informed the minister that they are adding a state-of-the-art laboratory focused on automation in the GV facility. KTR presented Hyderabad Pharma City project and highlighted the value proposition for companies like Sandoz. He invited Sandoz to consider setting up large manufacturing center in that.
He said, "Sandoz has chosen Hyderabad to setup their GCC. The city boasts a top-notch business environment backed by the State, with a strong emphasis on the life sciences industry. It is already home to Novartis and has grown into second largest location for the company. We are looking forward to a similar patronage and association with Sandoz."
As a division of the Novartis Group, the company's vision is to discover new ways to improve and extend people's lives. The global portfolio of Sandoz comprises of approximately 1,000 molecules, covering all major therapeutic areas, which accounted for 2019 sales of $9.7 billion. Their products reach more than 500 million patients globally. Hyderabad is regarded the life sciences capital of India and vaccine capital of the world.
